Biomimetic metal-organic frameworks navigated biological bombs for efficient lung cancer therapy

J Colloid Interface Sci. 2022 Nov:625:532-543. doi: 10.1016/j.jcis.2022.06.008. Epub 2022 Jun 7.

Abstract

The rising risk of lung cancer has become a primary global concern with high mortality and mobility. Presently, clinically used anticancer drugs show limited efficacy and significant side effects. A new generation of anticancer weapons is in great demand for lung cancer therapy. Herein, we have developed a novel style of biomimetic zeolitic imidazolate framework-8 (ZIF-8) based on the merits of cell membranes derived from human bone marrow mesenchymal stem cells (hBMSCs), which can navigate biological bombs herpes simplex virus type I thymidine kinase-encoded plasmids (pHSVtk) and ganciclovir (GCV) to treat lung cancer. The biological bomb-loaded structure can kill transfected lung cancer cells and neighboring lung cancer cells through the "bystander effect," which induces efficient suppression of lung cancer both in vitro and in vivo. The biomimetic nanoparticles show an enhanced circulation lifetime and drug accumulation in the tumor tissues and significantly inhibit the tumors. We have developed a straightforward approach to deliver biological bombs with biomimetic metal-organic frameworks for efficient lung cancer therapy. To the best of our knowledge, this is the first report of such a strategy for lung cancer therapy.

Keywords: Biological bombs; Bone marrow mesenchymal stem cells; Bystander effect; Lung cancer; Metal–organic frameworks.

MeSH terms

  • Biomimetics
  • Bombs*
  • Ganciclovir / pharmacology
  • Humans
  • Lung Neoplasms* / drug therapy
  • Metal-Organic Frameworks* / pharmacology

Substances

  • Metal-Organic Frameworks
  • Ganciclovir